After eight successful years at the helm of the Drexel University College of Medicine, Dr. Daniel V. Schidlow will step down as dean on June 30, 2019. That presents a special challenge, as we initiate the search for a successor.

Dean Schidlow will leave big shoes to fill. An internationally-recognized clinician in pediatric pulmonary diseases, Dr. Schidlow became the Walter H. and Leonore Annenberg Dean and senior vice president of medical affairs of the College in 2012, following eight months as interim dean. In that role, Dr. Schidlow has led one of the nation’s largest and most diverse medical schools, with more than 2,000 medical and graduate students.

During his tenure, he created a vision for and championed a complete renewal of the undergraduate medical education curriculum, overseeing its transformation to a modern, state-of- the-art model. In 2013, the College established the Graduate School of Biomedical Sciences and Professional Studies to enhance scientific and educational training.

A staunch supporter of the Drexel Pathway to Medical School program for under-represented minority students, he has actively engaged in increasing student and faculty diversity, as well as professional development for emerging faculty leadership, including the creation of the deanships of Diversity, Equity and Inclusion and of Faculty Development. In an increasingly competitive environment, the College of Medicine under Dean Schidlow’s leadership has grown a successful research enterprise and promoted the college’s leading participation roles in regional and national research consortia.

In a further expansion of the College under Dr. Schidlow, Tower Health and Drexel University recently announced exciting plans to jointly develop a branch medical school campus near Reading Hospital.

One out of every four applicants to U.S. medical schools sought a place at the Drexel University College of Medicine this past year – and that’s a proud legacy for Dean Schidlow.